|
Real-time
Euronext Bruxelles
07:36:55 2026-09-01 am EDT
|
5-day change | 1st Jan Change | ||
| 220.00 EUR | +2.18% |
|
0.00% | -7.80% |
| 05:59am | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Aug. 31 | Trump announces new round of drug-pricing deals | RE |
| Market Cap | 41.05B 47.68B 38.54B 35.18B 66.1B 4,536B 66.57B 457B 178B 2,300B 179B 175B 7,617B | P/E 2026 * |
21.6x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 41.36B 48.03B 38.83B 35.45B 66.59B 4,570B 67.07B 460B 179B 2,317B 180B 176B 7,673B | EV / Sales 2026 * |
4.75x | EV / Sales 2027 * | 4.05x |
| Free-Float |
61.59% | Yield 2026 * |
0.68% | Yield 2027 * | 0.7% |
Last Transcript : UCB
| 1 day | +2.18% | ||
| Current month | -1.30% | ||
| 1 month | -1.30% | ||
| 3 months | -13.45% | ||
| 6 months | -13.01% | ||
| Current year | -7.80% |
| 1 week | 215.4 |  | 226.2 |
| 1 month | 211.6 | | 232.9 |
| Current year | 211.6 | | 289.5 |
| 1 year | 191.2 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 60 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/15/26 | Exercice | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Exercice | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Buy | Director | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.18% | 0.00% | +10.44% | +165.70% | 47.68B | |
| +0.62% | -3.55% | +38.27% | -3.32% | 79.79B | |
| +0.43% | +1.89% | -18.05% | -37.01% | 58.85B | |
| +1.70% | +1.04% | +480.16% | +24.12% | 56.03B | |
| +2.15% | -2.13% | -1.37% | +30.77% | 51.26B | |
| -0.85% | -0.67% | +55.16% | -18.97% | 32.01B | |
| -0.92% | -3.72% | +43.31% | +90.95% | 24.98B | |
| -2.12% | +2.11% | -3.61% | +189.46% | 23.05B | |
| +1.65% | +1.02% | +61.34% | +115.78% | 16.31B | |
| -3.91% | -3.91% | -8.84% | +773.77% | 15.64B | |
| Average | -0.25% | -0.75% | +65.68% | +133.13% | 40.56B | |
| Weighted average by Cap. | +0.14% | -1.34% | +81.24% | +70.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.7B 10.1B 8.17B 7.46B 14.01B 961B 14.11B 96.8B 37.66B 488B 37.94B 37.12B 1,614B | 9.68B 11.25B 9.09B 8.3B 15.59B 1,070B 15.7B 108B 41.92B 543B 42.23B 41.31B 1,797B |
| Net income | 1.93B 2.24B 1.81B 1.66B 3.11B 214B 3.13B 21.51B 8.37B 108B 8.43B 8.25B 359B | 2.33B 2.7B 2.19B 1.99B 3.75B 257B 3.77B 25.9B 10.08B 130B 10.15B 9.93B 432B |
| Net Debt | 306M 355M 287M 262M 492M 33.76B 495M 3.4B 1.32B 17.12B 1.33B 1.3B 56.69B | -1.81B -2.1B -1.7B -1.55B -2.91B -200B -2.93B -20.11B -7.83B -101B -7.88B -7.71B -335B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | €220.00 | +2.18% | 51,517 |
| 26-08-31 | €215.30 | -0.55% | 312,155 |
| 26-08-28 | €216.50 | -2.43% | 257,379 |
| 26-08-27 | €221.90 | +0.41% | 228,212 |
| 26-08-26 | €221.00 | -1.38% | 197,178 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions
